We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1157:HKEXZoomlion Heavy Industry Science and Technology Co., Ltd. Analysis

Data as of 2026-06-02 - not real-time

HK$7.21

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Zoomlion trades at HKD 7.21, sitting just above its calculated support of 7.10 and well below the resistance of 8.58, indicating limited upside in the immediate term. The RSI 14‑day of 32.5 and a bearish MACD histogram suggest the stock is currently oversold and momentum is turning negative, while volume trends are decreasing, reinforcing a near‑term hold stance.
The company boasts a PE of 12.43 versus an industry average of 29.79 and a PB of 0.92, flagging it as undervalued on a pure valuation basis. A dividend yield of 10.74% with a 99.6% payout appears attractive, yet free cash flow is negative (‑5.2 bn) and debt‑to‑equity is high (66.1), raising concerns on dividend sustainability. Recent material news highlights the launch of a new MEWP Intelligent Factory in Hungary and accelerated deployment of ultra‑large hydraulic excavators, underscoring strategic expansion and potential revenue tailwinds despite the current cash‑flow strain.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish MACD and low RSI indicating near‑term momentum weakness
  • decreasing volume trend reducing short‑term liquidity
  • price positioned just above support limiting upside potential

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • significant valuation discount (PE 12.4 vs industry 29.8)
  • strategic European factory expansion enhancing growth outlook
  • high dividend yield despite cash‑flow concerns

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • consistent undervaluation on PE/PB metrics
  • low beta (0.5) and modest volatility indicating defensive profile
  • strong cash reserves and expanding product portfolio supporting sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth6.90%
Profit Margin8.18%
P/E Ratio12.4
ROE7.41%
ROA1.92%
Debt/Equity66.12
P/B Ratio0.9
Op. Cash FlowHK$5.1B
Free Cash FlowHK$-5213478912
Industry P/E29.8

Technical Analysis

TrendNeutral
RSI32.5
SupportHK$7.10
ResistanceHK$8.58
MA 20HK$7.69
MA 50HK$8.22
MA 200HK$7.93
MACDBearish
VolumeDecreasing
Fear & Greed Index92.77

Valuation

Fair ValueHK$5.09
Target PriceHK$9.35
Upside/Downside29.64%
GradeUndervalued
TypeValue
Dividend Yield10.74%

Risk Assessment

Beta0.40
Volatility34.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.